Monitoring daily activity in patients with pulmonary hypertension
Activity Monitoring in Pulmonary Hypertension
This study is testing if tracking daily activities can help people with pulmonary hypertension understand their health better compared to the standard 6-minute walk test.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 230 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT04101630 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the prognostic value of daily activity tracking compared to the 6-minute walk distance (6MWD) in patients with pulmonary hypertension over a 12-week period. Participants will use activity trackers and report their outcomes, including quality of life and any changes in medication or hospitalization. The study will enroll 500 patients and will be conducted annually for four years, focusing on the relationship between daily activity levels and clinical factors affecting pulmonary hypertension. The goal is to establish the clinical utility of activity monitoring in this patient population.
Who should consider this trial
Good fit: Ideal candidates include patients in the United States with confirmed pulmonary hypertension who are enrolled in L-PVDOMICS or have a clinical diagnosis supported by hemodynamics.
Not a fit: Patients who are pregnant, recently hospitalized, or have orthopedic limitations that prevent them from participating in the 6MWD test may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into how daily activity levels impact the prognosis of patients with pulmonary hypertension.
How similar studies have performed: While this approach is observational and builds on existing knowledge, it aims to provide new insights into the prognostic value of activity monitoring in pulmonary hypertension, making it a novel exploration in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Enrolled in L-PVDOMICS or * Any patient in the United States with pulmonary hypertension confirmed by hemodynamics and expert clinical diagnosis Exclusion Criteria: * Pregnancy * Hospitalization within the prior 3 months * Orthopedic limitations that preclude 6MWD testing
Where this trial is running
Nashville, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: Evan L Brittain, MD — Vanderbilt University Medical Center
- Study coordinator: Alisha Lindsey
- Email: alisha.lindsey@vumc.org
- Phone: 937-638-2416
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.